Carroll Financial Associates’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $2.51M | Sell |
24,031
-131
| -0.5% | -$15.2K | 0.13% | 100 |
|
|
2021
Q3 | $3.03M | Sell |
24,162
-310
| -1% | -$40.1K | 0.17% | 89 |
|
|
2021
Q2 | $3.04M | Sell |
24,472
-229
| -0.9% | -$28.8K | 0.17% | 87 |
|
|
2021
Q1 | $2.92M | Sell |
24,701
-340
| -1% | -$39.8K | 0.18% | 81 |
|
|
2020
Q4 | $2.93M | Sell |
25,041
-514
| -2% | -$56.6K | 0.2% | 76 |
|
|
2020
Q3 | $2.65M | Sell |
25,555
-625
| -2% | -$62.8K | 0.2% | 76 |
|
|
2020
Q2 | $2.4M | Buy |
26,180
+1,541
| +6% | +$148K | 0.2% | 75 |
|
|
2020
Q1 | $2.22M | Buy |
24,639
+6,614
| +37% | +$704K | 0.22% | 71 |
|
|
2019
Q4 | $2.04M | Buy |
18,025
+419
| +2% | +$46K | 0.16% | 87 |
|
|
2019
Q3 | $1.91M | Sell |
17,606
-62
| -0.4% | -$6.47K | 0.17% | 85 |
|
|
2019
Q2 | $1.72M | Buy |
17,668
+514
| +3% | +$46.9K | 0.15% | 93 |
|
|
2019
Q1 | $1.56M | Buy |
17,154
+141
| +0.8% | +$12.6K | 0.15% | 90 |
|
|
2018
Q4 | $1.4M | Sell |
17,013
-11
| -0.1% | -$1.03K | 0.16% | 88 |
|
|
2018
Q3 | $1.67M | Buy |
17,024
+65
| +0.4% | +$6.01K | 0.18% | 84 |
|
|
2018
Q2 | $1.45M | Sell |
16,959
-512
| -3% | -$42.8K | 0.15% | 92 |
|
|
2018
Q1 | $1.4M | Buy |
17,471
+414
| +2% | +$34.1K | 0.15% | 91 |
|
|
2017
Q4 | $1.38M | Buy |
17,057
+524
| +3% | +$42K | 0.15% | 90 |
|
|
2017
Q3 | $1.31M | Buy |
16,533
+1,825
| +12% | +$152K | 0.15% | 90 |
|
|
2017
Q2 | $1.3M | Sell |
14,708
-384
| -3% | -$32.4K | 0.16% | 90 |
|
|
2017
Q1 | $1.22M | Buy |
15,092
+4,575
| +44% | +$357K | 0.15% | 89 |
|
|
2016
Q4 | $749K | Sell |
10,517
-1,888
| -15% | -$148K | 0.11% | 112 |
|
|
2016
Q3 | $1.07M | Buy |
12,405
+573
| +5% | +$49.9K | 0.16% | 85 |
|
|
2016
Q2 | $1.03M | Buy |
11,832
+160
| +1% | +$12.9K | 0.17% | 85 |
|
|
2016
Q1 | $875K | Buy |
11,672
+387
| +3% | +$29.1K | 0.16% | 87 |
|
|
2015
Q4 | $868K | Sell |
11,285
-273
| -2% | -$20.6K | 0.18% | 89 |
|
|
2015
Q3 | $848K | Sell |
11,558
-7
| -0.1% | -$516 | 0.19% | 88 |
|
|
2015
Q2 | $857K | Buy |
11,565
+6,864
| +146% | +$524K | 0.19% | 82 |
|
|
2015
Q1 | $367K | Hold |
4,701
| – | – | 0.16% | 97 |
|
|
2014
Q4 | $348K | Buy |
4,701
+3,329
| +243% | +$231K | 0.22% | 79 |
|
|
2014
Q3 | $94K | Sell |
1,372
-210
| -13% | -$13.4K | 0.03% | 227 |
|
|
2014
Q2 | $101K | Buy |
1,582
+220
| +16% | +$13.4K | 0.03% | 232 |
|
|
2014
Q1 | $84K | Buy |
1,362
+142
| +12% | +$8.27K | 0.03% | 236 |
|
|
2013
Q4 | $70K | Hold |
1,220
| – | – | 0.02% | 242 |
|
|
2013
Q3 | $64K | Buy |
1,220
+75
| +7% | +$4.04K | 0.02% | 250 |
|
|
2013
Q2 | $58K | Buy |
+1,145
| New | +$56.6K | 0.03% | 216 |
|
Other funds holding MDT
Carroll Financial Associates's MDT Position: Q4 2021 in Review
Carroll Financial Associates reduced its Medtronic (MDT) stake by 0.54% in Q4 2021, selling an estimated $15.2K and leaving 24,031 shares worth $2.51M. The position accounts for 0.13% of the portfolio, ranked #100.
Carroll Financial Associates first reported a position in MDT in Q2 2013 and has held it in 35 quarters since. The position peaked at $3.04M in Q2 2021. 2,059 funds tracked by Wall St. Rank hold MDT as of Q4 2021.
- Carroll Financial Associates held 24,031 shares of Medtronic worth $2.51M as of Q4 2021.
- Carroll Financial Associates sold 131 Medtronic shares in Q4 2021, an estimated $15.2K.
- Medtronic made up 0.13% of Carroll Financial Associates's portfolio in Q4 2021, its #100 holding.
- Carroll Financial Associates first reported a position in Medtronic in Q2 2013 and has held it in 35 quarters since.
- Carroll Financial Associates's Medtronic position peaked at $3.04M in Q2 2021.
- 2,059 funds tracked by Wall St. Rank held Medtronic as of Q4 2021.
Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.